Vascular Inflammation and the Renin-Angiotensin System

Atherosclerosis--an inflammatory disease

Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients

(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663

Acute-Phase Proteins and Other Systemic Responses to Inflammation

Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734

Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction: Results of the Survival and Ventricular Enlargement Trial

Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504

NAD(P)H Oxidase: Role in Cardiovascular Biology and Disease

Griendling, K. K., Sorescu, D., & Ushio-Fukai, M. (2000) · Circulation Research · doi:10.1161/01.res.86.5.494 · Cited by 2,886

Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells.

Griendling, K. K., Minieri, C. A., Ollerenshaw, J. D., & Alexander, R. W. (1994) · Circulation Research · doi:10.1161/01.res.74.6.1141 · Cited by 2,735

Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone.

Rajagopalan, S., Kurz, S. D., Münzel, T. F., Tarpey, M. M., Freeman, B. Α., Griendling, K. K., & Harrison, D. G. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118623 · Cited by 2,467

Plasma Concentration of Interleukin-6 and the Risk of Future Myocardial Infarction Among Apparently Healthy Men

Ridker, P. M., Rifai, N., Stampfer, M. J., & Hennekens, C. H. (2000) · Circulation · doi:10.1161/01.cir.101.15.1767 · Cited by 2,429

Involvement of a Novel Rac/RhoA Guanosine Triphosphatase-Nuclear Factor-κB Inducing Kinase Signaling Pathway Mediating Angiotensin II-Induced RelA Transactivation

Choudhary, S., Lu, M., Cui, R., & Brasier, A. R. (2007) · Molecular Endocrinology · doi:10.1210/me.2006-0465 · Cited by 24

Renal artery stenosis and accelerated atherosclerosis: which comes first?

Fava, C., Minuz, P., Patrignani, P., & Morganti, A. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000242388.92225.2c · Cited by 24

Increased Expression of Angiotensin II Type 1 Receptor (AGTR1) in Heart Transplant Recipients With Recurrent Rejection

Yamani, M. H., COOK, D. J., Rodríguez, E. R., Thomas, D., Gupta, S. K., Alster, J. M., Taylor, D. O., Hobbs, R. E., Young, J. B., Smedira, N. G., et al. (2006) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2006.09.012 · Cited by 23

Vascular effects of glycoprotein130 ligands — Part I: Pathophysiological role

Demyanets, S., Huber, K., & Wojta, J. (2011) · Vascular Pharmacology · doi:10.1016/j.vph.2011.12.004 · Cited by 23

Anti-Inflammatory Subfractions Separated from Acidified Chloroform Fraction of Fenugreek Seeds (Trigonella foenum-graecum L.)

Pournamdari, M., Mandegary, A., Sharififar, F., Zarei, G., Zareshahi, R., Asadi, A., & Mehdipour, M. (2017) · Journal of Dietary Supplements · doi:10.1080/19390211.2017.1326431 · Cited by 23

The Role of Angiotensin II in Parietal Epithelial Cell Proliferation and Crescent Formation in Glomerular Diseases

Rizzo, P., Novelli, R., Rota, C., Gagliardini, E., Ruggiero, B., Rottoli, D., Benigni, A., & Remuzzi, G. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.07.004 · Cited by 23

Kallistatin limits abdominal aortic aneurysm by attenuating generation of reactive oxygen species and apoptosis

Krishna, S. M., Li, J., Wang, Y., Moran, C. S., Trollope, A. F., Huynh, P., Jose, R. J., Biroš, E., Ma, J., & Golledge, J. (2021) · Scientific Reports · doi:10.1038/s41598-021-97042-8 · Cited by 22

Association between the plasma proteome and serum ascorbic acid concentrations in humans

Costa, L. A. D., García‐Bailo, B., Borchers, C. H., Badawi, A. F., & El‐Sohemy, A. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.05.002 · Cited by 22

Suppressive Effects of Irbesartan on Inflammation and Apoptosis in Atherosclerotic Plaques of apoE−/− Mice: Molecular Imaging with 14C-FDG and 99mTc-Annexin A5

Zhao, Y., Watanabe, A., Zhao, S., Kobayashi, T., Fukao, K., Tanaka, Y., Nakano, T., Yoshida, T., Takemoto, H., Tamaki, N., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089338 · Cited by 22

Critical Roles of Reactive Oxygen Species in Age‐Related Impairment in Ischemia‐Induced Neovascularization by Regulating Stem and Progenitor Cell Function

Lam, Y. T. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/7095901 · Cited by 22

Silent Effects of High Salt: Risks Beyond Hypertension and Body’s Adaptation to High Salt

Kazi, R. N. A. (2025) · Biomedicines · doi:10.3390/biomedicines13030746 · Cited by 24

Revisiting renin-angiotensin-aldosterone system in aging: translational insights from bench to bedside and back

Coşarderelioğlu, Ç., & Abadir, P. M. (2025) · Journal of Clinical Investigation · doi:10.1172/jci195633 · Cited by 24

Do multiple nuclear factor kappa B activation mechanisms explain its varied effects in the heart?

Kumar, R., Yong, Q. C., & Thomas, C. (2013) · Europe PMC (PubMed Central) · Cited by 21

Pigment-epithelium-derived factor (PEDF) inhibits angiotensin-II-induced vascular endothelial growth factor (VEGF) expression in MOLT-3 T cells through anti-oxidative properties

Yamagishi, S., Matsui, T., Nakamura, K., Yoshida, T., Shimizu, K., Takegami, Y., Shimizu, T., Inoue, H., & Imaizumi, T. (2006) · Microvascular Research · doi:10.1016/j.mvr.2006.03.001 · Cited by 21

C-Reactive Protein and Incident Left Ventricular Hypertrophy in Essential Hypertension

Assadi, F. K. (2007) · Pediatric Cardiology · doi:10.1007/s00246-006-0173-2 · Cited by 21

Irbesartan inhibits human T‐lymphocyte activation through downregulation of activator protein‐1

Cheng, S., Yang, S., Ho, L., Tsao, T., Chang, D., & Lai, J. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705785 · Cited by 21

Pravastatin Prevents Aortic Atherosclerosis via Modulation of Signal Transduction and Activation of Transcription 3 (STAT3) to Attenuate Interleukin-6 (IL-6) Action in ApoE Knockout Mice

Zhou, X., Li, D., Yan, W., & Li, W. (2008) · International Journal of Molecular Sciences · doi:10.3390/ijms9112253 · Cited by 21

Effects of the Angiotensin II Type 1 Receptor Antagonist Telmisartan on Monocyte Adhesion and Activation in Patients with Essential Hypertension

Syrbe, U., MOEBES, A., Scholze, J., Swidsinski, A. V., & Dörffel, Y. (2007) · Hypertension Research · doi:10.1291/hypres.30.521 · Cited by 21

Vitamin D and the Renin-Angiotensin System

Li, Y. C. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-381978-9.10040-x · Cited by 21

Risk‐Based Classification of Hypertension and the Role of Combination Therapy

Weir, M. R. (2008) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2007.08134.x · Cited by 21

The Role of Inflammation as a Preponderant Risk Factor in Cardiovascular Diseases

García, R. D., Asensio, J. A., Perdicaro, D. J., & Peral, M. D. L. Á. (2022) · Current Vascular Pharmacology · doi:10.2174/1570161120666220201160038 · Cited by 21

Local Bone Marrow Renin-Angiotensin System and Atherosclerosis

Beyazıt, Y., Pürnak, T., Guven, G. S., & Haznedaroğlu, İ. C. (2010) · Cardiology Research and Practice · doi:10.4061/2011/714515 · Cited by 20

Smoking and Atherosclerotic Cardiovascular Disease: Part I: Atherosclerotic Disease Process

Winkelmann, B. R., von Holt, K., & Unverdorben, M. (2009) · Biomarkers in Medicine · doi:10.2217/bmm.09.32 · Cited by 20

Angiotensin blockade in diabetic patients decreases insulin resistance‐associated low‐grade inflammation

Pavlatou, M. G., Mastorakos, G. P., Margeli, A., Kouskouni, E. E., Tentolouris, N., Katsilambros, N., Chrousos, G. P., & Papassotiriou, I. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02453.x · Cited by 19

Influence of Leisure-Time Physical Activity on the Relationship between C-Reactive Protein and Hypertension in a Community-Based Elderly Population of Japan: The Tsurugaya Project

Niu, K., Hozawa, A., Fujita, K., Ohmori, K., Okutsu, M., Kuriyama, S., Tsuji, I., & Nagatomi, R. (2005) · Hypertension Research · doi:10.1291/hypres.28.747 · Cited by 19

The role of the renin–angiotensin system in malignant vascular injury affecting the systemic and cerebral circulations

Collidge, T., Lammie, G. A., Fleming, S., & Mullins, J. J. (2004) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2003.11.003 · Cited by 19

Influence of the 4G/5G PAI-1 genotype on angiotensin II-stimulated human endothelial cells and in patients with hypertension

Roncal, C., Orbe, J., Rodríguez, J. A., Belzunce, M., Beloqui, Ó., Dı́ez, J., & Páramo, J. A. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.03.023 · Cited by 19

Pioglitazone produces rapid and persistent reduction of vascular inflammation in patients with hypertension and type 2 diabetes mellitus who are receiving angiotensin II receptor blockers

Takase, H., Nakazawa, A., Yamashita, S., Toriyama, T., Sato, K., Ueda, R., & Dohi, Y. (2007) · Metabolism · doi:10.1016/j.metabol.2007.01.002 · Cited by 19

Type 2 diabetes-induced cardiovascular complications: comparative evaluation of spironolactone, atenolol, metoprolol, ramipril and perindopril

Patel, B. M., & Bhadada, S. V. (2013) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2013.827699 · Cited by 19

Metabolism and chromatin dynamics in health and disease

Rodriguez, H., Rafehi, H., Bhave, M. R., & El‐Osta, A. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.09.004 · Cited by 18

Adiponectin ameliorates angiotensin II-induced vascular endothelial damage

Zhi, Z., Pengfei, Z., Xiaoyi, T., & Ma, G. (2014) · Cell Stress and Chaperones · doi:10.1007/s12192-014-0498-3 · Cited by 18

Angiotensin receptor type 1 polymorphism A1166C is associated with altered AT1R and miR-155 expression in carotid plaque tissue and development of hypoechoic carotid plaques

Stanković, A., Kolaković, A., Živković, M., Djurić, T., Bundalo, M., KONCAR, I. B., Davidovic, L. B., & Alavantić, D. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.02.032 · Cited by 19

The role of Immunity in Fabry Disease and Hypertension: A Review of a Novel Common Pathway

Pinto, R. D., & Ferri, C. (2020) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-020-00414-w · Cited by 18

Losartan benefits over atenolol in non‐smoking hypertensive patients with left ventricular hypertrophy: The LIFE study

Reims, H. M., Oparil, S., Kjeldsen, S. E., Devereux, R. B., Julius, S., Brady, W. E., Fyhrquist, F., Ibsen, H., Lindholm, L. H., Omvik, P., et al. (2004) · Blood Pressure · doi:10.1080/08037050410016483 · Cited by 18

Angiotensin type 2 receptor is expressed in human atherosclerotic lesions

Johansson, M. E., Fagerberg, B., & Bergström, G. M. L. (2008) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.3317/jraas.2008.005 · Cited by 18

Perindopril protects against streptozotocin-induced hyperglycemic myocardial damage/alterations

Patel, B. M., Agarwal, S., & Bhadada, S. (2012) · Human & Experimental Toxicology · doi:10.1177/0960327112446817 · Cited by 18

Valsartan inhibits angiotensin II-induced proliferation of vascular smooth muscle cells via regulating the expression of mitofusin 2

Liao, H., Gong, J., Zhang, W., & Guo, X. (2012) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-012-0005-y · Cited by 18

Distinct Components of Janus Kinase/Signal Transducer and Activator of Transcription Signaling Pathway Mediate the Regulation of Systemic and Tissue Localized Renin-Angiotensin System

Guo, Y., Mascareno, E. J., & Siddiqui, M. A. Q. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0231 · Cited by 18

Angiotensin I-Converting Enzyme Gene Polymorphism Enhances the Effect of Hypercholesterolemia on the Risk of Coronary Heart Disease in a General Japanese Population: The Hisayama Study

Kondo, H., Ninomiya, T., Hata, J., Hirakawa, Y., Yonemoto, K., Arima, H., Nagata, M., Tsuruya, K., Kitazono, T., & Kiyohara, Y. (2014) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.24166 · Cited by 17

Bromodomain‐containing protein 4 and its role in cardiovascular diseases

Li, L., Xie, W., Gui, Y., & Zheng, X. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30225 · Cited by 17

Association of angiotensin-converting enzyme gene I/D and CYP11B2 gene −344T/C polymorphisms with lone atrial fibrillation and its recurrence after catheter ablation

Zhang, X.-L., Wu, L., Liu, X., Yang, Y., Tan, H., Wang, X., Zhou, L., Jiang, W., & Li, Z. (2012) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2012.650 · Cited by 17

Comparative Effects of Candesartan and Amlodipine in a Monkey Atherosclerotic Model

Takai, S., Jin, D., SAKAGUCHI, M., Muramatsu, M., Ishii, K., Kirimura, K., Sakonjo, H., & Miyazaki, M. (2004) · Hypertension Research · doi:10.1291/hypres.27.517 · Cited by 17

Manipulation of the Renin Angiotensin System in Peripheral Arterial Disease

Hobbs, S. D., Thomas, M. E., & Bradbury, A. W. (2004) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2004.08.003 · Cited by 17

CircMETTL14(11)S upregulated METTL14 and induced CXCR4 to aggravate endothelial inflammation and atherosclerosis

Kang, P., & Dong, P. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110979 · Cited by 16

Influence of Renal Sympathetic Denervation on Cardiac Extracellular Matrix Turnover and Cardiac Fibrosis

Dörr, O., Liebetrau, C., Möllmann, H., Gaede, L., Troidl, C., Morczeck, K., Wiebe, J., Hoffmann, J., Voss, S., Bauer, T., et al. (2015) · American Journal of Hypertension · doi:10.1093/ajh/hpv020 · Cited by 16

Cardiomyocyte‐Specific Snrk Prevents Inflammation in the Heart

Thirugnanam, K., Cossette, S. M., Lu, Q., Chowdhury, S. R., Harmann, L. M., Gupta, A., Spearman, A. D., Sonin, D. L., Bordas, M. L., Kumar, S. N., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012792 · Cited by 16

Neonatal HDL Counteracts Placental Vascular Inflammation via S1P–S1PR1 Axis

Gaudio, I. D., Hendrix, S., Christoffersen, C., & Wadsack, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030789 · Cited by 14

Multi-omic signatures of atherogenic dyslipidaemia: pre-clinical target identification and validation in humans

Olkowicz, M., Czyżyńska-Cichoń, I., Szupryczyńska, N., Kostogrys, R. B., Kochan, Z., Dȩbski, J., Dadlez, M., Chłopicki, S., & Smolenski, R. T. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-020-02663-8 · Cited by 16

Evaluation of Angiotensin Converting Enzyme (ACE)-Like Activity of Acellular Hemoglobin

Simoni, J. M., Simoni, G., Moeller, J. F., Tsikouris, J. P., & Wesson, D. E. (2007) · Artificial Cells Blood Substitutes and Biotechnology · doi:10.1080/10731190601188273 · Cited by 16

Expression profiles in surgically‐induced carotid stenosis: a combined transcriptomic and proteomic investigation

Forte, A., Finicelli, M., Luca, P. D., Quarto, C., Onorati, F., Santè, P., Renzulli, A., Galderisi, U., Berrino, L., FEO, M. D., et al. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00212.x · Cited by 16

Review: Atrial fibrillation and renin-angiotensin system

Serra, J. L. P., & Bendersky, M. (2008) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944708092111 · Cited by 16

The relationship between 24-hour ambulatory blood pressure load and neutrophil-to-lymphocyte ratio

Çimen, T., Sunman, H., Efe, T. H., Erat, M., Şahan, H. F., Algül, E., Gulıyev, İ., Akyel, A., Doğan, M., Açıkel, S., et al. (2017) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2016.07.009 · Cited by 16

Angiotensin II induces cell growth and IL-6 mRNA expression through the JAK2-STAT3 pathway in rat cerebellar astrocytes

Kandalam, U., Marimuthu, P., & Clark, M. A. (2012) · JAK-STAT · doi:10.4161/jkst.19688 · Cited by 16

Vascular Endothelial Function in Periodontal Disease: Role of Inflammation

Higashi, Y., & Taguchi, A. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.125.045720 · Cited by 20

Phenolics: therapeutic applications against oxidative injury in obesity and type 2 diabetes pathology

Salau, V. F., Erukainure, O. L., & Islam, M. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815972-9.00029-9 · Cited by 15

Effect of high-dose valsartan on inflammatory and lipid parameters in patients with Type 2 diabetes and hypertension

Kintscher, U., Marx, N., Martus, P., Stoppelhaar, M., Schimkus, J., Schneider, A., Walcher, D., Kümmel, A., Winkler, R., Kappert, K., et al. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.04.018 · Cited by 15

Effects of olmesartan, an AT1 receptor antagonist, on hypoxia-induced activation of ERK1/2 and pro-inflammatory signals in the mouse lung

Tanabe, Y., Morikawa, Y., Kato, T., Kanai, S., Watakabe, T., Ami, N., Iwata, H., Isobe, K., Ishizaki, M., & Nakayama, K. (2006) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-006-0110-1 · Cited by 15

RNA Interference of Myocyte Enhancer Factor 2A Accelerates Atherosclerosis in Apolipoprotein E-Deficient Mice

Zhou, W., Zhang, H., Zhao, Y., Liu, G., & Zhang, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121823 · Cited by 15

Effects of telmisartan and valsartan on insulin sensitivity in obese diabetic mice

Ushijima, K., Takuma, M., Ando, H., Ishikawa-Kobayashi, E., Nozawa, M., Maekawa, T., Shiga, T., & Fujimura, A. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.11.022 · Cited by 15

Rationale and design of the NAGOYA HEART Study: Comparison between valsartan and amlodipine regarding morbidity and mortality in patients with hypertension and glucose intolerance

Matsushita, K., Muramatsu, T., Kondo, T., Maeda, K., Shintani, S., & Murohara, T. (2010) · Journal of Cardiology · doi:10.1016/j.jjcc.2010.03.004 · Cited by 15

Is Systemic Inflammation of Hemodialysis Patients Improved With the Use of Enalapril? Results of a Randomized, Double-Blinded, Placebo-Controlled Clinical Trial

Ordaz-Medina, S. M., Plascencia, J. G., Martín-del-Campo, F., Campos, E. R., Montañez-Fernández, J. L., Espinoza‐Gómez, F., & Cueto-Manzano, A. M. (2010) · ASAIO Journal · doi:10.1097/mat.0b013e3181c1d830 · Cited by 15

Molecular cloning of liver angiotensinogen gene in ayu (Plecoglossus altivelis) and mRNA expression changes upon Aeromonas hydrophila infection

CHEN, J., SHI, Y., Li, M., DING, W., & Niu, H. (2008) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2008.01.015 · Cited by 15

Beyond blood pressure, fluid and electrolyte homeostasis – Role of the renin angiotensin aldosterone system in the interplay between metabolic diseases and breast cancer

Kalupahana, N. S., & Moustaïd‐Moussa, N. (2024) · Acta Physiologica · doi:10.1111/apha.14164 · Cited by 15

Renin‐Angiotensin System Blocker Use May Be Associated with Suppression of Atrial Fibrillation Recurrence after Pulmonary Vein Isolation

Ishikawa, K., Yamada, T., Yoshida, Y., Takigawa, M., Aoyama, Y., Inoue, N., Tatematsu, Y., Nanasato, M., Kato, K., Tsuboi, N., et al. (2010) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2010.02949.x · Cited by 14

Myocardial migration by fibroblast progenitor cells is blood pressure dependent in a model of angII myocardial fibrosis

Rosin, N. L., Sopel, M. J., Falkenham, A., Myers, T. L., & Légaré, J. (2012) · Hypertension Research · doi:10.1038/hr.2011.217 · Cited by 14

The emerging role of subclinical inflammation in hypertension-associated early renal dysfunction: focus on microalbuminuria.

Tsioufis, C. P., Dimitriadis, K. S., Stefanadis, C., & Kallikazaros, I. E. (2006) · PubMed · Cited by 13

Clinical, Research and Treatment Approaches to Affective Disorders

Juruena, M. F. (2012) · InTech eBooks · doi:10.5772/1482 · Cited by 14

Atherosclerosis: From Genetic Polymorphisms to System Genetics

Cambien, F., & Tiret, L. (2005) · Cardiovascular Toxicology · doi:10.1385/ct:5:2:143 · Cited by 14

Haemostatic and inflammatory alterations in familial hypercholesterolaemia, and the impact of angiotensin II infusion

Ekholm, M., Kahan, T., Jörneskog, G., Brinck, J. W., & Wallén, N. H. (2015) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320315575848 · Cited by 13

Beneficial Effects of Rosuvastatin Treatment in Patients With Metabolic Syndrome

Bostan, C., Yıldız, A., Özkan, A. A., Uzunhasan, I., Kaya, A., & Yiğit, Z. (2014) · Angiology · doi:10.1177/0003319714522107 · Cited by 13

Increased Fetal Cardiovascular Disease Risk: Potential Synergy Between Gestational Diabetes Mellitus and Maternal Hypercholesterolemia

Espinoza, C., Fuenzalida, B., & Leiva, A. (2021) · Current Vascular Pharmacology · doi:10.2174/1570161119666210423085407 · Cited by 13

A CCR2/CCR5 Antagonist Attenuates an Increase in Angiotensin II-Induced CD11b+ Monocytes from Atherogenic ApoE−/− Mice

Major, T. C., Olszewski, B., & Rosebury, W. S. (2008) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-008-6157-0 · Cited by 13

Receptor-associated prorenin system in the pathogenesis of retinal diseases

Ishida, S. (2012) · Frontiers in Bioscience-Scholar · doi:10.2741/s345 · Cited by 13

The −344T>C promoter variant of the gene for aldosterone synthase (CYP11B2) is not associated with cardiovascular risk in a prospective study of UK healthy men

Payne, J. R., Dhamrait, S. S., Toor, I. S., Cooper, J. A., Jones, A., Miller, G. J., Humphries, S. E., & Montgomery, H. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.01.004 · Cited by 13

Effects of irbesartan and perindopril on forearm reactive hyperemia and inflammatory process, in normotensive patientswith coronary artery disease

Tousoulis, D., Kourtellaris, P., Antoniades, C. A., Vasiliadou, C., Παπαγεωργίου, Ν., Tentolouris, C. A., Siasos, G., Stefanadi, E., & Stefanadis, C. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.11.206 · Cited by 13

Adrenomedullin antagonizes angiotensin II-stimulated proliferation of human aortic smooth muscle cells

Rossi, F., Bertone, C., Petricca, S., & Santiemma, V. (2006) · Peptides · doi:10.1016/j.peptides.2006.05.003 · Cited by 12

Drug-induced immunomodulation to affect the development and progression of atherosclerosis: a new opportunity?

Heeneman, S., Donners, M. M. P. C., Bai, L., & Daemen, M. J. A. P. (2007) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.5.2.345 · Cited by 13

Inhibiting angiotensin-converting enzyme promotes renal repair by modulating progenitor cell activation

Rizzo, P., Novelli, R., Benigni, A., & Remuzzi, G. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.04.009 · Cited by 12

The mechanism of low-level arsenic exposure-induced hypertension: Inhibition of the activity of the angiotensin-converting enzyme 2

Rahaman, M. S., Mise, N., Ikegami, A., Zong, C., Ichihara, G., & Ichihara, S. (2023) · Chemosphere · doi:10.1016/j.chemosphere.2023.137911 · Cited by 12

Angiotensin II induces EMMPRIN expression in THP-1 macrophages via the NF-κB pathway

Yang, L., Liu, H. S., Guo, R., Ye, J., Wang, X., Qi, F., Chuan-ming, G., & Liang, X. (2010) · Regulatory Peptides · doi:10.1016/j.regpep.2010.04.012 · Cited by 12

In prehypertension leukocytosis is associated with body mass index but not with blood pressure or incident hypertension

Julius, S., Egan, B. M., Kaciroti, N., Nesbitt, S. D., & Chen, A. K. (2013) · Journal of Hypertension · doi:10.1097/hjh.0000000000000032 · Cited by 12

Non‐Surgical Periodontal Therapy Improves Serum Levels of C‐Reactive Protein and Edematous States in Female Patients With Idiopathic Edema

Joseph, R., Narayan, V., Krishnan, R., & Melemadathil, S. (2010) · Journal of Periodontology · doi:10.1902/jop.2010.100258 · Cited by 13

Comparison of fimasartan and amlodipine therapy on carotid atherosclerotic plaque inflammation

Oh, M., Lee, C. W., Ahn, J., Park, D., Kang, S., Lee, S., Kim, Y., Moon, D. H., Park, S., & Park, S. (2018) · Clinical Cardiology · doi:10.1002/clc.23133 · Cited by 12

Agonistic antibody to angiotensin II type 1 receptor accelerates atherosclerosis in ApoE-/- mice.

Li, W., Chen, Y., Li, S., Guo, X., Zhou, W., Zeng, Q., Liao, Y., & Wei, Y. (2014) · Europe PMC (PubMed Central) · Cited by 12

Candesartan With Pioglitazone Protects Against Endothelial Dysfunction and Inflammatory Responses in Porcine Coronary Arteries Implanted With Sirolimus-Eluting Stents

Dohi, T., Miyauchi, K., Iesaki, T., Tsuruta, R., Tsuboi, S., Ogita, M., Kubota, N., Kasai, T., Yokoyama, T., & Daida, H. (2011) · Circulation Journal · doi:10.1253/circj.cj-10-0917 · Cited by 12

Oxidative Stress in Mononuclear Cells Plays a Dominant Role in Their Adhesion to Mouse Femoral Artery After Injury

Hagita, S., Osaka, M., Shimokado, K., & Yoshida, M. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.098855 · Cited by 12

Inflammation in early atherogenesis: impact of ACE inhibition

Caterina, R. D., & Manes, C. (2003) · European Heart Journal Supplements · doi:10.1093/oxfordjournals.ehjsupp.a000771 · Cited by 12

Research progress on the correlation between renin-angiotensin-aldosterone system (RAAS) and cardiovascular and cerebrovascular diseases

Zhao, G., Wang, T., Luan, Y., Xu, Y., Qin, N., Chen, W., & Wang, Q. (2025) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/14703203251351194 · Cited by 11

Association of the KLK1 rs5516 G allele and the ACE D allele with aortic aneurysm and atherosclerotic stenosis

Zhang, Y., Huang, H., Ma, Y., Sun, Y., Wang, G., & Tang, L. (2016) · Medicine · doi:10.1097/md.0000000000005120 · Cited by 10

Chronopharmacology of Angiotensin II–receptor Blockers in Stroke-Prone Spontaneously Hypertensive Rats

Liu, Y., Ushijima, K., Ohmori, M., Takada, M., Tateishi, M., Ando, H., & Fujimura, A. (2011) · Journal of Pharmacological Sciences · doi:10.1254/jphs.10284fp · Cited by 11

Regulation of oxidative stress inside living cells through polythiophene derivatives

Hu, R., Li, S.-L., Bai, H., Wang, Y., Liu, L., Lv, F., & Wang, S. (2016) · Chinese Chemical Letters · doi:10.1016/j.cclet.2016.02.001 · Cited by 11

Red alga polysaccharides attenuate angiotensin II-induced inflammation in coronary endothelial cells

Hamias, R., Wolak, T., Huleihel, M., Paran, E., & Levy‐Ontman, O. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.04.206 · Cited by 11

Vascular inflammation is a missing link for diabetes-enhanced atherosclerotic cardiovascular diseases

Najeeb, A. (2011) · Frontiers in bioscience · doi:10.2741/3978 · Cited by 11

Beneficial Effects of Angiotensin II Type 1 Receptor Blocker Antihypertensive Treatment on Inflammation Indices: The Effect of Smoking

Kyvelou, S.-M., Vyssoulis, G. P., Karpanou, E. A., Adamopoulos, D. N., Gialernios, T. P., Pietri, P. G., Cokkinos, D. V., & Stefanadis, C. (2007) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2007.05819.x · Cited by 11

Apolipoprotein-J prevents angiotensin II-induced apoptosis in neonatal rat ventricular cells

Ma, Y., Kong, L., Nan, K., Qi, S., Ru, L., Ding, C., & Wang, D. (2015) · Lipids in Health and Disease · doi:10.1186/s12944-015-0118-y · Cited by 11

Epigenetic Contribution to the Development and Progression of Vascular Diabetic Complications

Rodriguez, H., & El‐Osta, A. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7347 · Cited by 11

Biochemical Mechanisms of Cellular Stress Adaptation in the Pathogenesis of Chronic Diseases

Lemanowicz, J., Kloska, S. M., Siwik-Ziomek, A., Kołaczyk, P., Lipińska, U. W., & Kłoska, A. (2026) · Molecules · doi:10.3390/molecules31091381 · Cited by 14

Dysregulated homocysteine metabolism and cardiovascular disease and clinical treatments

Cao, X., Wang, T., Mu, G., Chen, Y., Xiang, B., Zhu, J., & Shen, Z. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05284-1 · Cited by 10

Lentiviral-mediated RNA interference of lipoprotein-associated phospholipase A2 ameliorates inflammation and atherosclerosis in apolipoprotein E-deficient mice

ZHANG, H., Zhang, J., Shen, D., ZHANG, L., HE, F., Dang, Y. H., & Li, L. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1248 · Cited by 10

Peroxisome Proliferator-Activated Receptor α Attenuates Hypertensive Vascular Remodeling by Protecting Vascular Smooth Muscle Cells from Angiotensin II-Induced ROS Production

Liu, Y., Duan, Y., Zhao, N., Zhu, X., Yu, X., Jiao, S., Song, Y., Li, S., Ma, Y., Wang, X., et al. (2022) · Antioxidants · doi:10.3390/antiox11122378 · Cited by 10

Angiotensin II and vascular inflammation.

Cheng, Z. J., Vapaatalo, H., & Mervaala, E. M. A. (2005) · PubMed · Cited by 236

Role of the Renin-Angiotensin System in Vascular Diseases

Ruiz‐Ortega, M., Lorenzo, Ó., Rupérez, M., Esteban, V., Suzuki, Y., Mezzano, S. A., Plaza, J. J. G., & Egido, J. (2001) · Hypertension · doi:10.1161/hy1201.100589 · Cited by 317

Angiotensin Induces Inflammatory Activation of Human Vascular Smooth Muscle Cells

Kranzhöfer, R., Schmidt, J., Pfeiffer, C. A. H., Hagl, S., Libby, P., & Kübler, W. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.7.1623 · Cited by 483

Angiotensin II and atherosclerosis

Weiss, D., Sorescu, D., & Taylor, W. R. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01539-9 · Cited by 180

From endothelial dysfunction to vascular occlusion: role of the renin-angiotensin system.

Silva, P. M. (2010) · PubMed · Cited by 10